Clinical Trials Directory

Trials / Conditions / Stage IIB Prostate Cancer AJCC v8

Stage IIB Prostate Cancer AJCC v8

24 registered clinical trials studyying Stage IIB Prostate Cancer AJCC v8 — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingEffects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
NCT06330805
Ohio State University Comprehensive Cancer CenterPhase 2
RecruitingSBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcino
NCT06205316
Mayo ClinicPhase 3
RecruitingrhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Acti
NCT05852041
Northwestern UniversityEARLY_Phase 1
Active Not RecruitingRElugolix VErsus LeUprolide Cardiac Trial
NCT05320406
Emory UniversityPhase 2
SuspendedRobot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
NCT04981834
University of Southern CaliforniaN/A
Active Not RecruitingNeoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer
NCT04985565
M.D. Anderson Cancer CenterN/A
Active Not RecruitingWhite Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Pro
NCT04519879
City of Hope Medical CenterPhase 2
TerminatedHealth Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation The
NCT04927559
University of Southern California—
Active Not RecruitingGermline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Tr
NCT04624256
Jonsson Comprehensive Cancer CenterN/A
TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
NCT04457245
Jonsson Comprehensive Cancer CenterPhase 3
CompletedAn Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prost
NCT04318028
University of Southern CaliforniaN/A
WithdrawnFocal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
NCT04399824
Jonsson Comprehensive Cancer CenterN/A
Active Not RecruitingLifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and T
NCT04189770
M.D. Anderson Cancer Center—
WithdrawnDaily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate
NCT04288336
Mayo ClinicEARLY_Phase 1
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
Active Not RecruitingAspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before
NCT03899987
Roswell Park Cancer InstitutePhase 2
Active Not RecruitingLifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
NCT04215029
M.D. Anderson Cancer CenterN/A
Active Not RecruitingComparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treat
NCT04253483
Rutgers, The State University of New JerseyPhase 2
WithdrawnHyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response
NCT03581500
M.D. Anderson Cancer CenterPhase 2
TerminatedOlaparib Before Surgery in Treating Participants With Localized Prostate Cancer
NCT03570476
University of WashingtonPhase 2
CompletedHypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatec
NCT03570827
Mayo ClinicPhase 2
Active Not RecruitingApalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy
NCT03412396
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingWatchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveill
NCT03575832
M.D. Anderson Cancer CenterN/A
CompletedApalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Particip
NCT03279250
M.D. Anderson Cancer CenterPhase 2